JPRN-UMIN000004911已完成1 期
Phase I clinical trial of epitope peptides based vaccines targeting VEGFR1 in patients with advanced renal cell carcinoma - Phase I clincal trial of epitope peptides based vaccines targeting VEGFR1 in patients with advanced renal cell carcinoma
Department of Urology, Kinki University School of Medicine0 个研究点目标入组 18 人开始时间: 2011年1月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •pregnancy uncontroled infection uncontroled cerebral metastasis etc
研究者
相似试验
已完成
1 期
Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.unresectable colorectal cancerJPRN-UMIN000000956Institute of Medical Science The University of Tokyo6
已完成
1 期
Phase I clinical study of peptide vaccine using novel tumor-associated antigen TTK against advanced esophageal carcinomaAdvanced esophageal cancer refractory to standard therapeutic modalityJPRN-UMIN000001014niversity of Tokyo6
已完成
1 期
PhaseI/II clinical study of peptide vaccine against advanced or recurrent gastric cancerAdvanced or recurrent gastric cancer refractory to standard therapeutic modalityJPRN-UMIN000004389Department of Gastroenterological Surgery,Graduate School of Medicine,Osaka University30
已完成
1 期
Phase I clinical trial of a mixed 20 peptides vaccine for castration-resistant prostate cancer (CRPC)JPRN-UMIN000008209Research Center for Innovative Cancer Therapy, Kurume University School of Medicine15
已完成
2 期
Phase II clinical trial of peptide vaccination with HLA-A2402-restricted KIF20A and VEGFR1 epitope peptides with gemcitabine chemotherapy in patients with unresectable advanced pancreatic cancerpancreatic cancerJPRN-UMIN000004641Department of Gastroenterology Juntendo University School of Medicine40